| Literature DB >> 28823960 |
Yang Kong1, Lufei Zhang1, Yu Huang1, Tianyu He1, Linshi Zhang1, Xinyi Zhao2, Xiaohu Zhou1, Dongkai Zhou1, Yingcai Yan1, Jiarong Zhou1, Haiyang Xie3, Lin Zhou3, Shusen Zheng4, Weilin Wang5.
Abstract
Pseudogenes are a subclass of long non-coding (lnc) RNAs that arose from protein-coding genes, but have lost the ability to produce proteins. Pseudogenes play an important role in the pathogenesis of various tumors; however, the role of pseudogenes in hepatocellular carcinoma (HCC) is poorly understood. In this study, we investigated a novel pseudogene, PDIA3P1, which was upregulated in HCC tissues compared with paired normal adjacent tissues. The expression of PDIA3P1 was significantly correlated with tumor size, metastasis, TNM stage, and overall stage. Knockdown of PDIA3P1decreased proliferation, migration, and invasion of HCC cells. PDIA3P1 knockdown also promoted cell apoptosis and inhibited tumor growth in vivo. We performed a GeneChip assay to investigate the underlying mechanism of PDIA3P1 action on biological function, and our results suggested that PDIA3P1 may promote proliferation and inhibit apoptosis of liver cancer cells by inhibiting the p53 pathway. Thus, our data suggest that PDIA3P1 acts as an oncogene in HCC and could be a potential prognostic marker and therapeutic target for HCC.Entities:
Keywords: Hepatocellular carcinoma; Long noncoding RNA; Pseudogene; p53
Mesh:
Substances:
Year: 2017 PMID: 28823960 DOI: 10.1016/j.canlet.2017.07.031
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679